Evidence map›Paper›PMID 20143642›Full record

Trial reportAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2010

Patterns of inhaled corticosteroid use and asthma control in the Childhood Asthma Management Program Continuation Study.

Gregory S Sawicki, Robert C Strunk, Brooke Schuemann, Robert Annett, Scott Weiss, Anne L Fuhlbrigge, Childhood Asthma Management Program Research Group

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Gregory S SawickiDivision of Respiratory Diseases, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA. gregory.sawicki@childrens.harvard.edu
Robert C Strunk
Brooke Schuemann
Robert Annett
Scott Weiss
Anne L Fuhlbrigge
Childhood Asthma Management Program Research Group
Brigham and Women's Hospital · USBoston Children's Hospital · USHarvard University · USUniversity of New Mexico · USWashington University in St. Louis · US

Funding

ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI KOSMISKI, LISA A. · 1985 to 2008
$52.6M
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI NEWCOMER, JOHN W. · 1985 to 2007
$25.4M
ZINC THERAPY FOR SCLERODERMA--PHASE I STUDYM01RR002719 · NCRR · JOHNS HOPKINS UNIVERSITY · PI EARLEY, CHRISTOPHER J · 1986 to 2007
$20.2M
CAMP Continuation Study/Phase 3U01HL075419 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI FUHLBRIGGE, ANNE L · 2003 to 2010
$2.0M
CLINICAL CENTER FOR CAMPN01HR016049 · HR · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 1991 to 2000
$1.0M
CLINICAL COORDINATING CENTER FOR CAMPN01HR016044 · HR · JOHNS HOPKINS UNIVERSITY · PI TONASCIA, JAMES A · 1991 to 2006
$729k
CLINICAL CENTER FOR CAMPN01HR016047 · HR · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI MACLUSKY, IAN B · 1991 to 2000
$0k
CLINICAL CENTER FOR CAMPN01HR016048 · HR · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J · 1991 to 2000
$0k
CLINICAL CENTER FOR CAMPN01HR016045 · HR · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI ZEIGER, ROBERT S · 1991 to 2001
$0k
CLINICAL CENTER FOR CAMPN01HR016051 · HR · WASHINGTON UNIVERSITY · PI STRUNK, ROBERT C · 1991 to 2000
$0k
CLINICAL CENTER FOR CAMPN01HR016052 · HR · JOHNS HOPKINS UNIVERSITY · PI ADKINSON, N FRANKLIN · 1991 to 2000
$0k
CLINICAL CENTER FOR CAMPN01HR016050 · HR · ASTHMA, INC. · PI SHAPIRO, GAIL G · 1991 to 2000
$0k
NCRR NIH HHS M01 RR000036NCRR NIH HHS M01 RR000051NCRR NIH HHS M01RR00051NCRR NIH HHS M01 RR002719NCRR NIH HHS M01RR0099718-24NCRR NIH HHS M01RR02719-14NCRR NIH HHS RR00036NHLBI NIH HHS N01 HR016044NHLBI NIH HHS N01 HR016045NHLBI NIH HHS N01 HR016046NHLBI NIH HHS N01 HR016047NHLBI NIH HHS N01 HR016048NHLBI NIH HHS N01 HR016049NHLBI NIH HHS N01 HR016050NHLBI NIH HHS N01 HR016051NHLBI NIH HHS N01 HR016052NHLBI NIH HHS N01-HR-16044NHLBI NIH HHS N01-HR-16045NHLBI NIH HHS N01-HR-16048NHLBI NIH HHS N01-HR-16049NHLBI NIH HHS N01-HR-16050NHLBI NIH HHS N01-HR-16051NHLBI NIH HHS N01-HR-16052NHLBI NIH HHS U01 HL075419
6 · The paper itself

Abstract

backgroundDaily controller medication use is recommended for children with persistent asthma to achieve asthma control.

objectiveTo examine patterns of inhaled corticosteroid (ICS) use and asthma control in an observational study of children and adolescents with mild-to-moderate asthma (the Childhood Asthma Management Program Continuation Study).

methodsWe assessed patterns of ICS use during a 12-month period (consistent, intermittent, and none) and asthma control (well controlled vs poorly controlled). Multivariate logistic regression examined the association between pattern of ICS use and asthma control.

resultsOf 914 patients enrolled, 425 were recommended to continue receiving ICS therapy in the Childhood Asthma Management Program Continuation Study. Of these patients, 46% reported consistent ICS use and 20% reported no ICS use during year 1. By year 4, consistent ICS use decreased to 20%, whereas no ICS use increased to 57%; poorly controlled asthma was reported in 18% of encounters. In multivariate models controlling for age, sex, forced expiratory volume in 1 second, and asthma severity assessment, patients reporting consistent ICS use during a 12-month period were more likely to report poor asthma control (odds ratio, 1.6; 95% confidence interval, 1.2-2.1) compared with those reporting no ICS use.

conclusionsIn this observational study of children and adolescents with mild-to-moderate asthma, most did not report continued use of ICS. Patients recommended to continue receiving ICS therapy and reporting consistent ICS use were less likely to report well-controlled asthma even after controlling for markers of asthma severity. Although residual confounding by severity cannot be ruled out, many children and adolescents may not achieve well-controlled asthma despite consistent use of ICS.

Indexed as

Medication Therapy ManagementAdolescentAdrenal Cortex HormonesAsthmaChildDisease ProgressionFollow-Up StudiesHumansInhalationPatient ComplianceAdrenal Cortex Hormones

Identifiers

PMID20143642
PMCPMC3040975
OpenAlexW2085767509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.